Psilocybin for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 19 registered trials.

Why this status

  1. 8 Feb 2024: Trial registered, NCT06247839
  2. 13 Mar 2024: Trial registered, NCT06308653
  3. 13 Mar 2024: Trial started, NCT06308653
  4. 10 Sep 2024: Trial started, NCT06247839
  5. 1 Apr 2026: Trial started, NCT07703722
  6. 14 Jul 2026: Trial registered, NCT07703722

The trials

NCT03181529: Effects of Psilocybin in Major Depressive Disorder

State
Completed
Phase
Phase 2
People
27 taking part
Started
10 Aug 2017
Primary completion
2 Dec 2020
Arms
Immediate Treatment, Delayed Treatment
Results
Posted on the registry
  1. 8 Jun 2017: Trial registered
  2. 10 Aug 2017: Trial started
  3. 2 Dec 2020: Trial completed
  4. 15 Dec 2021: Trial results posted

NCT03866174: A Study of Psilocybin for Major Depressive Disorder (MDD)

State
Completed
Phase
Phase 2
People
347 taking part
Started
23 Jan 2020
Primary completion
28 Jun 2022
Arms
Psilocybin
Results
Posted on the registry
  1. 7 Mar 2019: Trial registered
  2. 23 Jan 2020: Trial started
  3. 28 Jun 2022: Trial completed
  4. 22 Apr 2026: Trial results posted

NCT04593563: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

State
State not given
Phase
Phase 2
People
30 taking part
Started
1 Sep 2020
Primary completion
Oct 2022
Arms
Psilocybin 25mg
Results
None posted
  1. 1 Sep 2020: Trial started
  2. 20 Oct 2020: Trial registered

NCT04620759: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

State
Under way
Phase
Phase 2
People
90 planned
Started
14 Apr 2021
Primary completion
2 Mar 2026
Arms
Psilocybin Treatment
Results
None posted
  1. 9 Nov 2020: Trial registered
  2. 14 Apr 2021: Trial started

NCT04630964: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density

State
Completed
Phase
Phase 2
People
35 taking part
Started
1 Jan 2021
Primary completion
19 Apr 2023
Arms
psilocybin
Results
None posted
  1. 16 Nov 2020: Trial registered
  2. 1 Jan 2021: Trial started
  3. 18 Apr 2024: Trial completed

NCT05029466: Psilocybin for Treatment-Resistant Depression

State
Completed
Phase
Phase 2
People
30 taking part
Started
19 Nov 2021
Primary completion
22 Jul 2023
Arms
Immediate treatment, Delayed treatment
Results
None posted
  1. 31 Aug 2021: Trial registered
  2. 19 Nov 2021: Trial started
  3. 22 Jul 2023: Trial completed

NCT05220410: The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

State
Completed
Phase
Phase 2
People
20 taking part
Started
28 Mar 2022
Primary completion
12 May 2025
Arms
Psilocybin
Results
None posted
  1. 2 Feb 2022: Trial registered
  2. 28 Mar 2022: Trial started
  3. 12 May 2025: Trial completed

NCT05259943: Microdosing Psychedelics to Improve Mood

State
Completed
Phase
Phase 2
People
39 taking part
Started
15 Jul 2023
Primary completion
21 Dec 2024
Arms
Blinded Psilocybin, Open Label
Results
None posted
  1. 2 Mar 2022: Trial registered
  2. 15 Jul 2023: Trial started
  3. 1 Feb 2025: Trial completed

NCT05399498: Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

State
Completed
Phase
Phase 2
People
10 taking part
Started
1 Nov 2023
Primary completion
1 Dec 2025
Arms
Experimental: Psilocybin
Results
Posted on the registry
  1. 1 Jun 2022: Trial registered
  2. 1 Nov 2023: Trial started
  3. 1 Dec 2025: Trial completed
  4. 29 Oct 2026: Trial results posted

NCT05594667: Effect of SSRIs on Response to Psilocybin Therapy

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
1 Jan 2023
Primary completion
14 Mar 2023
Arms
PEX010
Results
None posted
  1. 26 Oct 2022: Trial registered
  2. 1 Jan 2023: Trial started
  3. 6 Jul 2023: Trial withdrawn

NCT05601648: PET Synaptogenesis After Psilocybin In DEpression Recovery

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
1 Jul 2023
Primary completion
1 Jan 2025
Arms
Psilocybin
Results
None posted
  1. 1 Nov 2022: Trial registered
  2. 30 Jan 2023: Trial withdrawn

NCT05675800: Psilocybin for Major Depressive Disorder

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
1 Jan 2024
Primary completion
1 Jan 2025
Arms
Psilocybin Active Dose Treatment A, Psilocybin Active Dose Treatment B
Results
None posted
  1. 9 Jan 2023: Trial registered
  2. 25 Jul 2024: Trial withdrawn

NCT05947383: Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

State
Under way
Phase
Phase 2
People
56 planned
Started
23 Oct 2023
Primary completion
30 Apr 2027
Arms
Psilocybin
Results
None posted
  1. 17 Jul 2023: Trial registered
  2. 23 Oct 2023: Trial started

NCT06230757: Psilocybin for Treatment-Resistant Depression

State
Completed
Phase
Phase 2
People
20 taking part
Started
8 Jul 2024
Primary completion
8 May 2026
Arms
Psilocybin
Results
None posted
  1. 30 Jan 2024: Trial registered
  2. 8 Jul 2024: Trial started
  3. 8 May 2026: Trial completed

NCT06247839: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

State
Under way
Phase
Phase 3
People
20 planned
Started
10 Sep 2024
Primary completion
30 Jun 2028
Arms
Psilocybin
Results
None posted
  1. 8 Feb 2024: Trial registered
  2. 10 Sep 2024: Trial started

NCT06308653: Psilocybin for Major Depressive Disorder (MDD)

State
Under way
Phase
Phase 3
People
238 taking part
Started
13 Mar 2024
Primary completion
5 Jan 2026
Arms
Psilocybin 25 mg
Results
None posted
  1. 13 Mar 2024: Trial registered
  2. 13 Mar 2024: Trial started

NCT07405606: Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder

State
Under way
Phase
Phase 2
People
30 planned
Started
23 Mar 2026
Primary completion
Mar 2028
Arms
Psilocybin (25 mg)
Results
None posted
  1. 12 Feb 2026: Trial registered
  2. 23 Mar 2026: Trial started

NCT07703722: Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder

State
Under way
Phase
Phase 3
People
60 planned
Started
1 Apr 2026
Primary completion
22 Oct 2027
Arms
Psilocybin Therapy
Results
None posted
  1. 1 Apr 2026: Trial started
  2. 14 Jul 2026: Trial registered

NCT07895134: Psilocybin for Depression in Veterans

State
Not started
Phase
Phase 2
People
150 planned
Started
1 Jan 2027
Primary completion
31 Dec 2031
Arms
Psilocybin arm
Results
None posted
  1. 26 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as High Dose Psilocybin, Low Dose Psilocybin, Medium Dose Psilocybin, Psilocybin (0.25mg/kg), Psilocybin (Usona Institute), Psilocybin (drug), Psilocybin 100 mcg/kg, Psilocybin 25 mg, Psilocybin 25 mg per os, Psilocybin 25mg, Psilocybin assisted therapy, Psilocybin first, Psilocybin plus Visual Healing Set and Setting, Psilocybin therapy, psilocybin 25 mg sod.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.